HighTower Advisors
BTMD icon

HighTower Advisors’s Biote Corp BTMD Stock Holding History

HighTower Advisors’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,863
Closed -$182K – 3649
2023
Q4 		$182K Sell
36,863
-10,000
-21% -$51.5K ﹤0.01% 3043
2023
Q3 		$240K Sell
46,863
-16,393
-26% -$96.6K ﹤0.01% 2770
2023
Q2 		$428K Buy
+63,256
New +$375K ﹤0.01% 2307

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SIM
SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighTower Advisors's BTMD Position: Q1 2024 in Review

HighTower Advisors sold out of Biote Corp (BTMD) in Q1 2024, closing a stake of 36,863 shares — an estimated $182K sold.

HighTower Advisors first reported a position in BTMD in Q2 2023 and held it in 3 quarters. The position peaked at $428K in Q2 2023. 54 funds tracked by Wall St. Rank hold BTMD as of Q1 2024.

  • HighTower Advisors reported no remaining Biote Corp position as of Q1 2024 after selling out during the quarter.
  • HighTower Advisors sold 36,863 Biote Corp shares in Q1 2024, an estimated $182K.
  • HighTower Advisors first reported a position in Biote Corp in Q2 2023 and held it in 3 quarters.
  • HighTower Advisors's Biote Corp position peaked at $428K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Biote Corp as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.